PranaX Corporation ( an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop ...

A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over 30 years of research, the trial reprograms ...

The licensed technology was part of the first FDA approved trial to test mesenchymal stem cell derived exosomes in cancer patients. The company's first commercial product, ExoWELL™, is a ...

Say goodbye to hair loss with exosome therapy Explore how exosomes work to stimulate hair follicles and enhance hair density ...

While the trial focuses on stem cell transplantation, it hints at broader mechanisms—like exosome release—that could transform Parkinson's care by repairing brain damage and enhancing dopamine ...

Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial ...

RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the ...

Currently, doctors do not treat breast cancer patients with obesity-driven diabetes any differently than those without ...